Yongfu Shao

Small non-coding RNAs: key regulatory factors and potential therapeutic targets in tumor immunity

Downregulated STAT3 and STAT5B are prognostic biomarkers for colorectal cancer and are associated with immune infiltration

Global progress and future prospects of early gastric cancer screening

Analysis of Helicobacter pylori resistance in patients with different gastric diseases

Machine learning to establish three sphingolipid metabolism genes signature to characterize the immune landscape and prognosis of patients with gastric cancer

Antibiotic resistance in <i>Helicobacter pylori</i>: From potential biomolecular mechanisms to clinical practice

Biological and clinical implications of hsa_circ_0086720 in gastric cancer and its clinical application

The tRNA-derived fragment 5026a inhibits the proliferation of gastric cancer cells by regulating the PTEN/PI3K/AKT signaling pathway

Biological roles and potential clinical values of circular RNAs in gastrointestinal malignancies

Hsa_circ_0001020 Serves as a Potential Biomarker for Gastric Cancer Screening and Prognosis

Circular RNA MTO1 suppresses tumorigenesis of gastric carcinoma by sponging miR‐3200-5p and targeting PEBP1

Hsa_circ_0065149 is an Indicator for Early Gastric Cancer Screening and Prognosis Prediction

Clinical significance of hsa_circ_0000419 in gastric cancer screening and prognosis estimation

Clinical significances of hsa_circ_0067582 and hsa_circ_0005758 in gastric cancer tissues

Global circular <scp>RNA</scp> expression profile of human gastric cancer and its clinical significance

Plasma circular RNA profiling of patients with gastric cancer and their droplet digital RT-PCR detection

Decreased expression of hsa_circ_0001895 in human gastric cancer and its clinical significances

Downregulated Expression of Hsa_Circ_0074362 in Gastric Cancer and Its Potential Diagnostic Values

Low expression of hsa_circ_0006633 in human gastric cancer and its clinical significances

Antibiotic resistance of <i>Helicobacter pylori</i> to 16 antibiotics in clinical patients

LncRNA-RMRP promotes carcinogenesis by acting as a miR-206 sponge and is used as a novel biomarker for gastric cancer

Plasma lncRNA-GACAT2 is a valuable marker for the screening of gastric cancer

Long noncoding RNA FER1L4 suppresses cancer cell growth by acting as a competing endogenous RNA and regulating PTEN expression

Using gastric juice lncRNA-ABHD11-AS1 as a novel type of biomarker in the screening of gastric cancer

Reduced expression of the long non-coding RNA AI364715 in gastric cancer and its clinical significance

Plasma long noncoding RNA protected by exosomes as a potential stable biomarker for gastric cancer

Long noncoding RNA associated-competing endogenous RNAs in gastric cancer

Gastric juice long noncoding RNA used as a tumor marker for screening gastric cancer

Increased expression of long intergenic non-coding RNA LINC00152 in gastric cancer and its clinical significance

Clinical significance of the low expression of FER1L4 in gastric cancer patients